Lenox Hill Hospital is First Reported Center in US to Treat a Rare Cause of Stroke with a New Device, the MVP
August 20, 2014
NEW YORK, NY – A Lenox Hill Hospital (LHH) neuro-endovascular surgeon was the first in the United States to report treating a rare cause of stroke using a new device that enables surgeons to use a minimally invasive procedure to stop blood flow, the North Shore-LIJ Health System announced today.
Rafael Alexander Ortiz, MD, LHH’s director of neuro-endovascular surgery and stroke, used the MVP® (Micro Vascular Plug System) manufactured by Reverse Medical of Irvine, Calif., to successfully treat a 71-year-old Staten Island woman.
The MVP device is designed as a less invasive alternative to open surgery when doctors need to close off arteries quickly and predictably. This device can be delivered in very small arteries to stop blood flow quickly and permanently.
Mrs. Rosa Melendez, 71, had suffered three strokes in the past year and her doctors could not determine the cause before being seen by the neuro-endovascular team at LHH, part of the North Shore-LIJ Health System.
“The medical work-up, including magnetic resonance imaging (MRI) and computed tomography (CT) scans, turned out to be negative all three times,” said Dr. Ortiz. “Mrs. Melendez was then referred to LHH’s neuro-endovascular team, where we performed a dynamic cerebral angiogram that revealed the cause of her strokes. We found that Mrs. Melendez had an artery in the back of her neck that kinked when she turned her head, causing blood clots to form that travelled to the arteries of the brain and resulted in strokes.”
Dr. Ortiz temporarily closed the artery causing the strokes by inflating a balloon inside the artery to test if she could tolerate a permanent blockage. Then he deployed the MVP device in the artery that was kinking to permanently close it. The procedure prevented clots from forming in that area and travelling to the arteries of the brain, preventing future strokes. Mrs. Melendez was discharged and sent home the next day.
In addition to this recent case, Dr. Ortiz has used the MVP device in six other patients to treat brain tumors, tumors of the head and neck, and spinal vascular tumors.
For more information or to see if you are a candidate for the MVP device, please call LHH’s neuro-endovascular team at 212-434-3900 or click here.
About the North Shore-LIJ Health System
One of the nation's largest health systems, North Shore-LIJ delivers world-class clinical care throughout the New York metropolitan area, pioneering research at The Feinstein Institute for Medical Research, a visionary approach to medical education highlighted by the Hofstra North Shore-LIJ School of Medicine, and healthcare coverage to individuals, families and businesses through the North Shore-LIJ CareConnect Insurance Co. Inc. North Shore-LIJ cares for people at every stage of life at 17 hospitals and more than 400 outpatient physician practices throughout the region. North Shore-LIJ’s owned hospitals and long-term care facilities house more than 6,000 beds, employ more than 10,000 nurses and have affiliations with over 9,400 physicians. With a workforce of about 48,000, North Shore-LIJ is the largest private employer in New York State. For more information, go to northshorelij.com.
Media Contacts:Michelle Pipia-Stiles, Freelance Publicist